{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T09:37:24Z","timestamp":1795081044079,"version":"4.10.2"},"reference-count":83,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>The 8th edition of the American Joint Committee on Cancer (AJCC) staging manual changed the tumor, node, metastasis (TNM) classification systems of genitourinary malignancies in 2017. However, some of the changes appear not well appreciated or recognized by practicing pathologists.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To review the major changes compared with the 7th edition in cancers of the prostate, penis, testis, bladder, urethra, renal pelvis\/ureter, and kidney and discuss the challenges that pathologists may encounter.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Sources.\u2014<\/jats:title>\n                    <jats:p>Peer-reviewed publications and the 8th and 7th editions of the AJCC Cancer Staging Manual.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>This article summarizes the updated staging of genitourinary malignancies, specifically highlighting changes from the 7th edition that are relevant to the pathologic staging system. Pathologists should be aware of the updates made in hopes of providing clarification and the remaining diagnostic challenges associated with these changes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2019-0544-ra","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T10:23:05Z","timestamp":1582712585000},"page":"305-319","source":"Crossref","is-referenced-by-count":45,"title":["Updates in Staging and Reporting of Genitourinary Malignancies"],"prefix":"10.5858","volume":"144","author":[{"given":"Kristine M.","family":"Cornejo","sequence":"first","affiliation":[{"name":"From the Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis","family":"Rice-Stitt","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Lee","family":"Wu","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","reference":[{"key":"2020081300335066100_i1543-2165-144-3-305-b01","unstructured":"Amin MB , EdgeSB, GreeneFL, et al. AJCC Cancer Staging Manual. 8th ed. Chicago, IL: Springer;2017."},{"key":"2020081300335066100_i1543-2165-144-3-305-b02","unstructured":"Edge SB , ByrdDR, ComptonCC, et al. AJCC Cancer Staging Manual. 7th ed. Chicago, IL: Springer;2011."},{"issue":"2","key":"2020081300335066100_i1543-2165-144-3-305-b03","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.eururo.2005.12.009","article-title":"The 2002 AJCC pT2 substages confer no prognostic information on the rate of biochemical recurrence after radical prostatectomy","volume":"49","author":"Chun","year":"2006","journal-title":"Eur Urol"},{"issue":"4","key":"2020081300335066100_i1543-2165-144-3-305-b04","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1464-410X.2008.07611.x","article-title":"The prognostic role of the pathological T2 subclassification for prostate cancer in the 2002 tumour-nodes-metastasis staging system","volume":"102","author":"van Oort","year":"2008","journal-title":"BJU Int"},{"issue":"1","key":"2020081300335066100_i1543-2165-144-3-305-b05","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/modpathol.2010.156","article-title":"International Society of Urological Pathology (ISUP) consensus conference on handling and staging of radical prostatectomy specimens: working group 2: T2 substaging and prostate cancer volume","volume":"24","author":"van der Kwast","year":"2011","journal-title":"Mod Pathol"},{"issue":"5","key":"2020081300335066100_i1543-2165-144-3-305-b06","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.juro.2009.07.020","article-title":"Pathological stage T2 subgroups to predict biochemical recurrence after prostatectomy","volume":"182","author":"Kordan","year":"2009","journal-title":"J Urol"},{"issue":"11","key":"2020081300335066100_i1543-2165-144-3-305-b07","doi-asserted-by":"crossref","first-page":"e0187887","DOI":"10.1371\/journal.pone.0187887","article-title":"Evaluation of the major changes in eighth edition of the American Joint Committee on Cancer pathological staging for prostate cancer treated with prostatectomy","volume":"12","author":"Xiao","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"2020081300335066100_i1543-2165-144-3-305-b08","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0000000000000820","article-title":"Contemporary Gleason grading of prostatic carcinoma: an update with discussion on practical issues to implement the 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma","volume":"41","author":"Epstein","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"2020081300335066100_i1543-2165-144-3-305-b09","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"2020081300335066100_i1543-2165-144-3-305-b10","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1464-410X.2012.11611.x","article-title":"Prognostic Gleason grade grouping: data based on the modified Gleason scoring system","volume":"111","author":"Pierorazio","year":"2013","journal-title":"BJU Int"},{"issue":"3","key":"2020081300335066100_i1543-2165-144-3-305-b11","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.eururo.2015.06.046","article-title":"A contemporary prostate cancer grading system: a validated alternative to the Gleason score","volume":"69","author":"Epstein","year":"2016","journal-title":"Eur Urol"},{"key":"2020081300335066100_i1543-2165-144-3-305-b12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13000-016-0478-2","article-title":"Grading of prostatic adenocarcinoma: current state and prognostic implications","volume":"11","author":"Gordetsky","year":"2016","journal-title":"Diagn Pathol"},{"issue":"10","key":"2020081300335066100_i1543-2165-144-3-305-b13","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/bjc.2016.86","article-title":"Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome","volume":"114","author":"Berney","year":"2016","journal-title":"Br J Cancer"},{"issue":"6","key":"2020081300335066100_i1543-2165-144-3-305-b14","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.eururo.2015.11.036","article-title":"Evaluation of the 2015 Gleason grade groups in a nationwide population-based cohort","volume":"69","author":"Loeb","year":"2016","journal-title":"Eur Urol"},{"issue":"22","key":"2020081300335066100_i1543-2165-144-3-305-b15","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1002\/cncr.27597","article-title":"Assessment of the American Joint Committee on Cancer staging (sixth and seventh editions) for clinically localized prostate cancer treated with external beam radiotherapy and comparison with the National Comprehensive Cancer Network risk-stratification method","volume":"118","author":"Zaorsky","year":"2012","journal-title":"Cancer"},{"issue":"11","key":"2020081300335066100_i1543-2165-144-3-305-b16","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.280.11.969","article-title":"Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer","volume":"280","author":"D'Amico","year":"1998","journal-title":"JAMA"},{"issue":"18","key":"2020081300335066100_i1543-2165-144-3-305-b17","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.1997.03540420041027","article-title":"Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update","volume":"277","author":"Partin","year":"1997","journal-title":"JAMA"},{"issue":"6","key":"2020081300335066100_i1543-2165-144-3-305-b18","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.juro.2017.06.085","article-title":"Independent validation of the American Joint Committee on Cancer 8th edition prostate cancer staging classification","volume":"198","author":"Bhindi","year":"2017","journal-title":"J Urol"},{"key":"2020081300335066100_i1543-2165-144-3-305-b19","doi-asserted-by":"crossref","unstructured":"Moch H , HumphreyPA, UlbrightTM, ReuterVE. WHO Classification of Tumours of the Urinary System and Male Genital Organs. Geneva, Switzerland: WHO Press;2016.","DOI":"10.1016\/j.eururo.2016.02.028"},{"issue":"5","key":"2020081300335066100_i1543-2165-144-3-305-b20","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/bju.12677","article-title":"Development and external validation of a prognostic tool for prediction of cancer-specific mortality after complete loco-regional pathological staging for squamous cell carcinoma of the penis","volume":"116","author":"Sun","year":"2015","journal-title":"BJU Int"},{"issue":"5","key":"2020081300335066100_i1543-2165-144-3-305-b21","doi-asserted-by":"crossref","first-page":"594","DOI":"10.6004\/jnccn.2013.0075","article-title":"Penile cancer: clinical practice guidelines in oncology","volume":"11","author":"Clark","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"issue":"7","key":"2020081300335066100_i1543-2165-144-3-305-b22","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1097\/PAS.0b013e3181641365","article-title":"Histologic grade and perineural invasion are more important than tumor thickness as predictor of nodal metastasis in penile squamous cell carcinoma invading 5 to 10 mm","volume":"32","author":"Velazquez","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"2020081300335066100_i1543-2165-144-3-305-b23","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/PAS.0b013e31819d17eb","article-title":"The prognostic index: a useful pathologic guide for prediction of nodal metastases and survival in penile squamous cell carcinoma","volume":"33","author":"Chaux","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"2020081300335066100_i1543-2165-144-3-305-b24","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.juro.2008.05.011","article-title":"Evaluation of current TNM classification of penile carcinoma","volume":"180","author":"Leijte","year":"2008","journal-title":"J Urol"},{"issue":"1","key":"2020081300335066100_i1543-2165-144-3-305-b25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40880-018-0340-x","article-title":"A modified clinicopathological tumor staging system for survival prediction of patients with penile cancer","volume":"38","author":"Li","year":"2018","journal-title":"Cancer Commun (Lond)"},{"issue":"12","key":"2020081300335066100_i1543-2165-144-3-305-b26","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1038\/bjc.2015.457","article-title":"Modification of N staging systems for penile cancer: a more precise prediction of prognosis","volume":"113","author":"Li","year":"2015","journal-title":"Br J Cancer"},{"issue":"1","key":"2020081300335066100_i1543-2165-144-3-305-b27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eururo.2014.10.017","article-title":"EAU guidelines on penile cancer: 2014 update","volume":"67","author":"Hakenberg","year":"2015","journal-title":"Eur Urol"},{"issue":"2","key":"2020081300335066100_i1543-2165-144-3-305-b28","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.juro.2011.03.104","article-title":"New N staging system of penile cancer provides a better reflection of prognosis","volume":"186","author":"Zhu","year":"2011","journal-title":"J Urol"},{"issue":"9","key":"2020081300335066100_i1543-2165-144-3-305-b29","doi-asserted-by":"crossref","first-page":"543.e1","DOI":"10.1016\/j.urolonc.2017.04.009","article-title":"Subclassification of pN3 staging systems for penile cancer: proposal for modification of the current TNM classification","volume":"35","author":"Li","year":"2017","journal-title":"Urol Oncol"},{"issue":"1","key":"2020081300335066100_i1543-2165-144-3-305-b30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/cam4.324","article-title":"Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance","volume":"4","author":"Chung","year":"2015","journal-title":"Cancer Med"},{"issue":"11","key":"2020081300335066100_i1543-2165-144-3-305-b31","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1093\/annonc\/mdu437","article-title":"Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG)","volume":"25","author":"Aparicio","year":"2014","journal-title":"Ann Oncol"},{"issue":"22","key":"2020081300335066100_i1543-2165-144-3-305-b32","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2002.01.038","article-title":"Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis","volume":"20","author":"Warde","year":"2002","journal-title":"J Clin Oncol"},{"issue":"1","key":"2020081300335066100_i1543-2165-144-3-305-b33","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/andr.280","article-title":"SWENOTECA. Surveillance vs. adjuvant therapy of clinical stage I testicular tumors\u2014a review and the SWENOTECA experience","volume":"3","author":"Cohn-Cedermark","year":"2015","journal-title":"Andrology"},{"issue":"12","key":"2020081300335066100_i1543-2165-144-3-305-b34","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1442-2042.2010.02645.x","article-title":"Outcome of different post-orchiectomy management for stage I seminoma: Japanese multi-institutional study including 425 patients","volume":"17","author":"Kamba","year":"2010","journal-title":"Int J Urol"},{"issue":"5","key":"2020081300335066100_i1543-2165-144-3-305-b35","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.purol.2015.01.009","article-title":"Surveillance of stage I testicular seminoma: 20 years oncological results [in French]","volume":"25","author":"Zores","year":"2015","journal-title":"Prog Urol"},{"issue":"6","key":"2020081300335066100_i1543-2165-144-3-305-b36","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.eururo.2015.07.044","article-title":"Guidelines on testicular cancer: 2015 update","volume":"68","author":"Albers","year":"2015","journal-title":"Eur Urol"},{"issue":"9","key":"2020081300335066100_i1543-2165-144-3-305-b37","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.humpath.2010.03.005","article-title":"Rete testis invasion by malignant germ cell tumor and\/or intratubular germ cell neoplasia: what is the significance of this finding?","volume":"41","author":"Vogt","year":"2010","journal-title":"Hum Pathol"},{"issue":"4","key":"2020081300335066100_i1543-2165-144-3-305-b38","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/modpathol.2012.189","article-title":"Testicular hilum and vascular invasion predict advanced clinical stage in nonseminomatous germ cell tumors","volume":"26","author":"Yilmaz","year":"2013","journal-title":"Mod Pathol"},{"issue":"4","key":"2020081300335066100_i1543-2165-144-3-305-b39","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.path.2018.07.005","article-title":"Updates in staging and reporting of testicular cancer","volume":"11","author":"Magers","year":"2018","journal-title":"Surg Pathol Clin"},{"issue":"3","key":"2020081300335066100_i1543-2165-144-3-305-b40","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/PAS.0000000000001008","article-title":"Idrees MT. the significance of spermatic cord involvement by testicular germ cell tumors: should we be staging discontinuous invasion from involved lymphovascular spaces differently from direct extension?","volume":"42","author":"Sanfrancesco","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"2020081300335066100_i1543-2165-144-3-305-b41","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/PAS.0000000000000917","article-title":"Do nonseminomatous germ cell tumors of the testis with lymphovascular invasion of the spermatic cord merit staging as pT3?","volume":"41","author":"Gordetsky","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"2020081300335066100_i1543-2165-144-3-305-b42","doi-asserted-by":"crossref","first-page":"824","DOI":"10.5858\/arpa.2016-0226-OA","article-title":"The significance of lymphovascular invasion of the spermatic cord in the absence of cord soft tissue invasion","volume":"141","author":"McCleskey","year":"2017","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"2020081300335066100_i1543-2165-144-3-305-b43","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1097\/PAS.0000000000000844","article-title":"Reporting and staging of testicular germ cell tumors: the International Society of Urological Pathology (ISUP) testicular cancer consultation conference recommendations","volume":"41","author":"Verrill","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"2020081300335066100_i1543-2165-144-3-305-b44","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.humpath.2005.06.017","article-title":"A new system for substaging pT1 papillary bladder cancer: a prognostic evaluation","volume":"36","author":"van der Aa","year":"2005","journal-title":"Hum Pathol"},{"issue":"3","key":"2020081300335066100_i1543-2165-144-3-305-b45","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/his.13247","article-title":"Stalk versus base invasion in pT1 papillary cancers of the bladder: improved substaging system predicting the risk of progression","volume":"71","author":"Lawless","year":"2017","journal-title":"Histopathology"},{"issue":"4","key":"2020081300335066100_i1543-2165-144-3-305-b46","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1365-2559.2011.03989.x","article-title":"Substaging by estimating the size of invasive tumour can improve risk stratification in pT1 urothelial bladder cancer\u2014evaluation of a large hospital-based single-centre series","volume":"59","author":"Bertz","year":"2011","journal-title":"Histopathology"},{"issue":"3","key":"2020081300335066100_i1543-2165-144-3-305-b47","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/PAS.0b013e31823dafd3","article-title":"Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection","volume":"36","author":"Chang","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"2020081300335066100_i1543-2165-144-3-305-b48","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13000-016-0466-6","article-title":"Usefulness of pT1 substaging in papillary urothelial bladder carcinoma","volume":"11","author":"Patriarca","year":"2016","journal-title":"Diagn Pathol"},{"issue":"2","key":"2020081300335066100_i1543-2165-144-3-305-b49","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.eururo.2011.10.026","article-title":"A new and highly prognostic system to discern T1 bladder cancer substage","volume":"61","author":"van Rhijn","year":"2012","journal-title":"Eur Urol"},{"issue":"8","key":"2020081300335066100_i1543-2165-144-3-305-b50","doi-asserted-by":"crossref","first-page":"361.e7","DOI":"10.1016\/j.urolonc.2018.05.007","article-title":"Metric substage according to micro and extensive lamina propria invasion improves prognostics in T1 bladder cancer","volume":"36","author":"Fransen van de Putte","year":"2018","journal-title":"Urol Oncol"},{"issue":"4","key":"2020081300335066100_i1543-2165-144-3-305-b51","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3892\/mco.2014.290","article-title":"Prognostic role of substaging in T1G3 transitional cell carcinoma of the urinary bladder","volume":"2","author":"DE Marco","year":"2014","journal-title":"Mol Clin Oncol"},{"issue":"1","key":"2020081300335066100_i1543-2165-144-3-305-b52","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.humpath.2012.04.020","article-title":"Prognostic factors in T1 bladder urothelial carcinoma: the value of recording millimetric depth of invasion, diameter of invasive carcinoma, and muscularis mucosa invasion","volume":"44","author":"Brimo","year":"2013","journal-title":"Hum Pathol"},{"issue":"2","key":"2020081300335066100_i1543-2165-144-3-305-b53","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.anndiagpath.2013.11.002","article-title":"Measuring the dimension of invasive component in pT1 urothelial carcinoma in transurethral resection specimens can predict time to recurrence","volume":"18","author":"Hu","year":"2014","journal-title":"Ann Diagn Pathol"},{"issue":"5","key":"2020081300335066100_i1543-2165-144-3-305-b54","doi-asserted-by":"crossref","first-page":"571","DOI":"10.5858\/arpa.2017-0539-RA","article-title":"Urinary bladder pathology: World Health Organization (WHO) classification and American Joint Committee on Cancer (AJCC) staging update","volume":"143","author":"Wang","year":"2019","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"2020081300335066100_i1543-2165-144-3-305-b55","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0000000000000964","article-title":"Analysis of T1 bladder cancer on biopsy and transurethral resection specimens: comparison and ranking of T1 quantification approaches to predict progression to muscularis propria invasion","volume":"42","author":"Leivo","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"2020081300335066100_i1543-2165-144-3-305-b56","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.eururo.2017.12.018","article-title":"Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers","volume":"73","author":"Paner","year":"2018","journal-title":"Eur Urol"},{"issue":"5","key":"2020081300335066100_i1543-2165-144-3-305-b57","doi-asserted-by":"crossref","first-page":"791","DOI":"10.5858\/133.5.791","article-title":"Histopathologic features and clinical outcomes in 71 cases of bladder diverticula","volume":"133","author":"Tamas","year":"2009","journal-title":"Arch Pathol Lab Med"},{"issue":"7","key":"2020081300335066100_i1543-2165-144-3-305-b58","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.humpath.2012.11.005","article-title":"The spectrum of histopathologic findings in vesical diverticulum: implications for pathogenesis and staging","volume":"44","author":"Idrees","year":"2013","journal-title":"Hum Pathol"},{"issue":"1","key":"2020081300335066100_i1543-2165-144-3-305-b59","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.urology.2013.02.015","article-title":"Histopathologic and clinical features of vesical diverticula","volume":"82","author":"Kong","year":"2013","journal-title":"Urology"},{"issue":"5","key":"2020081300335066100_i1543-2165-144-3-305-b60","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1097\/01.ju.0000091800.15071.52","article-title":"Carcinoma in a bladder diverticulum: presentation and treatment outcome","volume":"170","author":"Golijanin","year":"2003","journal-title":"J Urol"},{"issue":"10","key":"2020081300335066100_i1543-2165-144-3-305-b61","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00345-014-1472-5","article-title":"Urothelial carcinoma in bladder diverticula: outcomes after radical cystectomy","volume":"33","author":"Hu","year":"2015","journal-title":"World J Urol"},{"issue":"6 Pt 1","key":"2020081300335066100_i1543-2165-144-3-305-b62","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1097\/01.ju.0000095804.33714.ea","article-title":"The prognostic significance of metastatic perivesical lymph nodes identified in radical cystectomy specimens for transitional cell carcinoma of the bladder","volume":"170","author":"Bella","year":"2003","journal-title":"J Urol"},{"issue":"8","key":"2020081300335066100_i1543-2165-144-3-305-b63","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.urolonc.2014.08.004","article-title":"Significance of perivesical lymph nodes in radical cystectomy for bladder cancer","volume":"32","author":"Hu","year":"2014","journal-title":"Urol Oncol"},{"issue":"16","key":"2020081300335066100_i1543-2165-144-3-305-b64","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1002\/cncr.28146","article-title":"Nomogram for predicting survival in patients with unresectable and\/or metastatic urothelial cancer who are treated with cisplatin-based chemotherapy","volume":"119","author":"Galsky","year":"2013","journal-title":"Cancer"},{"issue":"10","key":"2020081300335066100_i1543-2165-144-3-305-b65","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1200\/JCO.1999.17.10.3173","article-title":"Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy","volume":"17","author":"Bajorin","year":"1999","journal-title":"J Clin Oncol"},{"issue":"4","key":"2020081300335066100_i1543-2165-144-3-305-b66","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/cncr.10762","article-title":"Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I\/II trial with paclitaxel, cisplatin, and gemcitabine","volume":"95","author":"Bellmunt","year":"2002","journal-title":"Cancer"},{"issue":"6","key":"2020081300335066100_i1543-2165-144-3-305-b67","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/bju.12486","article-title":"Urothelial carcinoma involving the prostate: the association of revised tumour stage and coexistent bladder cancer with survival after radical cystectomy","volume":"114","author":"Knoedler","year":"2014","journal-title":"BJU Int"},{"issue":"1","key":"2020081300335066100_i1543-2165-144-3-305-b68","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.juro.2012.09.006","article-title":"Validation of new AJCC exclusion criteria for subepithelial prostatic stromal invasion from pT4a bladder urothelial carcinoma","volume":"189","author":"Patel","year":"2013","journal-title":"J Urol"},{"issue":"1","key":"2020081300335066100_i1543-2165-144-3-305-b69","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0022-5347(05)64056-6","article-title":"Transitional cell carcinoma involving the prostate: a clinicopathological retrospective study of 76 cases","volume":"169","author":"Njinou Ngninkeu","year":"2003","journal-title":"J Urol"},{"issue":"3","key":"2020081300335066100_i1543-2165-144-3-305-b70","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0022-5347(01)65705-7","article-title":"Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion","volume":"156","author":"Esrig","year":"1996","journal-title":"J Urol"},{"issue":"1","key":"2020081300335066100_i1543-2165-144-3-305-b71","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0022-5347(01)66605-9","article-title":"Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer?: a necessary distinction for contiguous or noncontiguous involvement","volume":"155","author":"Pagano","year":"1996","journal-title":"J Urol"},{"issue":"1","key":"2020081300335066100_i1543-2165-144-3-305-b72","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00345-015-1583-7","article-title":"Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinoma","volume":"34","author":"Gakis","year":"2016","journal-title":"World J Urol"},{"issue":"9","key":"2020081300335066100_i1543-2165-144-3-305-b73","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/PAS.0000000000001087","article-title":"Challenges in pathologic staging of renal cell carcinoma: a study of interobserver variability among urologic pathologists","volume":"42","author":"Williamson","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2020081300335066100_i1543-2165-144-3-305-b74","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/modpathol.3800726","article-title":"Renal veins and venous extension in clear cell renal cell carcinoma","volume":"20","author":"Bonsib","year":"2007","journal-title":"Mod Pathol"},{"issue":"1","key":"2020081300335066100_i1543-2165-144-3-305-b75","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/his.13743","article-title":"Renal cell carcinoma staging: pitfalls, challenges, and updates","volume":"74","author":"Williamson","year":"2019","journal-title":"Histopathology"},{"issue":"2","key":"2020081300335066100_i1543-2165-144-3-305-b76","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/PAP.0b013e318032452e","article-title":"Renal cell carcinoma and the renal sinus","volume":"14","author":"Grignon","year":"2007","journal-title":"Adv Anat Pathol"},{"issue":"10","key":"2020081300335066100_i1543-2165-144-3-305-b77","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/PAS.0b013e318299f0fb","article-title":"The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters","volume":"37","author":"Delahunt","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2020081300335066100_i1543-2165-144-3-305-b78","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/his.13735","article-title":"Grading of renal cell carcinoma","volume":"74","author":"Delahunt","year":"2019","journal-title":"Histopathology"},{"issue":"3","key":"2020081300335066100_i1543-2165-144-3-305-b79","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/cncr.21206","article-title":"Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness","volume":"104","author":"Sengupta","year":"2005","journal-title":"Cancer"},{"issue":"2","key":"2020081300335066100_i1543-2165-144-3-305-b80","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/his.13737","article-title":"Assessment of tumour-associated necrosis provides prognostic information additional to World Health Organization\/International Society of Urological Pathology grading for clear cell renal cell carcinoma","volume":"74","author":"Dagher","year":"2019","journal-title":"Histopathology"},{"issue":"3","key":"2020081300335066100_i1543-2165-144-3-305-b81","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/PAS.0b013e318270f71c","article-title":"A novel grading system for clear cell renal cell carcinoma incorporating tumor necrosis","volume":"37","author":"Delahunt","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"2020081300335066100_i1543-2165-144-3-305-b82","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1097\/PAS.0000000000000690","article-title":"Tumor necrosis adds prognostically significant information to grade in clear cell renal cell carcinoma: a study of 842 consecutive cases from a single institution","volume":"40","author":"Khor","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"2020081300335066100_i1543-2165-144-3-305-b83","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/PAS.0000000000001025","article-title":"Architectural patterns are a relevant morphologic grading system for clear cell renal cell carcinoma prognosis assessment: comparisons with WHO\/ISUP grade and integrated staging systems","volume":"42","author":"Verine","year":"2018","journal-title":"Am J Surg Pathol"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/144\/3\/305\/2501137\/arpa_2019-0544-ra.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/144\/3\/305\/2501137\/arpa_2019-0544-ra.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:40:16Z","timestamp":1764790816000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/144\/3\/article-p305.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,1]]},"references-count":83,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2019-0544-ra","relation":{},"ISSN":["0003-9985","1543-2165"],"issn-type":[{"value":"0003-9985","type":"print"},{"value":"1543-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,1]]}}}